ABSTRACT
Nosocomial pneumonia is a healthcare-associated infection with significant consequences for the patient and the healthcare system. The efficacy of treatment significantly depends on the timeliness and adequacy of the antibiotic therapy regimen. The growth of resistance of gram-negative pathogens of nosocomial pneumonia to antimicrobial agents increases the risk of prescribing inadequate empirical therapy, which worsens the results of patient treatment. Identification of risk factors for infection with multidrug-resistant microorganisms, careful local microbiological monitoring with detection of resistance mechanisms, implementation of antimicrobial therapy control strategy and use of rational combinations of antibacterial drugs are of great importance. In addition, the importance of using new drugs with activity against carbapenem-resistant strains, including ceftazidime/aviabactam, must be understood. This review outlines the current data on the etiology, features of diagnosis and antibacterial therapy of nosocomial pneumonia.
Subject(s)
Cross Infection , Healthcare-Associated Pneumonia , Adult , Humans , Cross Infection/diagnosis , Cross Infection/drug therapy , Cross Infection/etiology , Anti-Bacterial Agents/adverse effects , Healthcare-Associated Pneumonia/diagnosis , Healthcare-Associated Pneumonia/drug therapy , Healthcare-Associated Pneumonia/complications , Ceftazidime/therapeutic use , Carbapenems/therapeutic useABSTRACT
Different strains of H. nana from man, Norway and white rats were studied in regards to their adaptability. Strains obtained from spontaneously infected white mice and those passaged for several years on white mice served as control. In the course of successive passages the infectivity of these strains, developmental rates of tissue larvae, localization of cystocercoids in the small intestine and mesenteric lymph glands were compared. The strains were found to possess different adaptability to white mice. The strain from white rats had the highest rate of adaptation, the strains from Norway rats and man showed lower adaptation rates, respectively.
